ArticleEuropean journal of nuclear medicine and molecular imaging2021

Predicting tumor response and prognosis to neoadjuvant chemotherapy in esophageal squamous cell carcinoma patients using PERCIST: a multicenter study in Japan.

Hayato Kaida et al.PubMed ↗Publisher ↗

No numbers read from the abstract.